We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Could Persistent CD30 Signaling Lead to Blood Cancers?

News   Apr 15, 2019 | Original story from Helmholtz Zentrum München

 
Could Persistent CD30 Signaling Lead to Blood Cancers?

Credit: Pixabay

 
 
 

RELATED ARTICLES

The Key to a Good Night’s Sleep?

News

A team of researchers has now created 3D maps of MT1 and MT2 melatonin receptors revealing the structural basis of the selectivity of each receptor subtype. They intend to use this structural information to design drug molecules that better target and bind to each of the two receptors.

READ MORE

Flu-fighting Properties of Elderberry Exist, says Food Industry

News

A research group from Sydney investigated the effect of elderberry extracts on viral replication in human cells.

READ MORE

Cryo-EM Material Advancements May Aid Medical Research

News

With new substrates, researchers have the potential to get all their data on the samples in as little as an hour, as opposed to what would currently take days.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE